P. Ting

发表

The synthesis and structure-activity relationship of 4-benzimidazolyl-piperidinylcarbonyl-piperidine analogs as histamine H3 antagonists.

Walter A. Korfmacher, M. Corboz, J. Hey, 2010, Bioorganic & medicinal chemistry letters.

Inhibition of fucosyltransferase VII by gallic acid and its derivatives.

S. Narula, D. Lundell, P. Ting, 2004, Archives of biochemistry and biophysics.

Identification of full, partial and inverse CC chemokine receptor 3 agonists using [35S]GTPgammaS binding.

Y. Wan, M. Billah, R. Egan, 2002, European journal of pharmacology.

Structure-activity relationships of oxime neurokinin antagonists: oxime modifications.

R. Aslanian, N. Shih, M. W. Mutahi, 2002, Bioorganic & medicinal chemistry letters.

The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: antagonists versus agonists.

Y. Wan, S. Umland, Jianhua Cao, 2005, Bioorganic & medicinal chemistry letters.

The synthesis of substituted bipiperidine amide compounds as CCR3 antagonists.

Y. Wan, S. Umland, Jianhua Cao, 2005, Bioorganic & medicinal chemistry letters.

Discovery of oral and inhaled PDE4 inhibitors.

Kung-I Feng, Jianhua Cao, R. Kuang, 2013, Bioorganic & medicinal chemistry letters.

Pharmacology of a potent and selective inhibitor of PDE4 for inhaled administration.

D. Lundell, R. Aslanian, R. Chapman, 2010, European journal of pharmacology.

SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.

M. Billah, R. Egan, M. Corboz, 2002, European journal of pharmacology.

Identification of a novel 1'-[5-((3,5-dichlorobenzoyl)methylamino)-3-(3,4-dichlorophenyl)-4-(methoxyimino)pentyl]-2-oxo-(1,4'-bipiperidine) as a dual NK(1)/NK(2) antagonist.

K. Ng, C. Rizzo, J. Hey, 2002, Bioorganic & medicinal chemistry letters.

Structure and activity relationships of tartrate-based TACE inhibitors.

P. Orth, Zhuyan Guo, C. Strickland, 2010, Bioorganic & medicinal chemistry letters.

The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.

Patrick J. Curran, P. Orth, Zhuyan Guo, 2010, Bioorganic & medicinal chemistry letters.

Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats.

J. Phillips, J. Hunter, R. Chapman, 2007, European journal of pharmacology.

The synthesis of substituted fluorenes as novel non-imidazole histamine h(3) inhibitors.

R. Aslanian, N. Shih, R. West, 2002, Bioorganic & medicinal chemistry letters.

Development of novel benzomorpholine class of diacylglycerol acyltransferase I inhibitors.

J. Lachowicz, J. Cook, S. Walker, 2014, ACS medicinal chemistry letters.

The synthesis of substituted bipiperidine amide compounds as CCR3 antagonists.

Y. Wan, S. Umland, Jianhua Cao, 2005, Bioorganic & medicinal chemistry letters.

Potent DGAT1 Inhibitors in the Benzimidazole Class with a Pyridyl-oxy-cyclohexanecarboxylic Acid Moiety.

Shirly Pinto, J. Lisnock, R. DeVita, 2013, ACS medicinal chemistry letters.

Substituted 1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-ones as potential antiinflammatory agents.

A. McPhail, R. Bryant, J. Lee, 1990, Journal of medicinal chemistry.

Preparation of Ethyl 1‐Benzyl‐4‐Fluoropiperidine‐4‐Carboxylate

T. Meng, P. Ting, J. Wong, 2011 .

Stereocontrolled synthesis of trans-2,5-disubstituted tetrahydrofurans

P. Bartlett, P. Ting, 1984 .

Radical cyclization of oxime ethers

P. Bartlett, P. Ting, K. L. Mclaren, 1988 .

Discovery of a Potent and Selective DGAT1 Inhibitor with a Piperidinyl-oxy-cyclohexanecarboxylic Acid Moiety.

Shirly Pinto, J. Lisnock, R. DeVita, 2014, ACS medicinal chemistry letters.

Discovery of a highly potent series of oxazole-based phosphodiesterase 4 inhibitors.

Xiaohong Zhu, H. Shue, R. Kuang, 2007, Bioorganic & medicinal chemistry letters.

Stereocontrolled synthesis of tetrahydrofurans and tetrahydropyrans using thallium(III)-induced cyclizations

P. Bartlett, J. Michael, P. Ting, 1985 .

Synthesis of spiro[4′,5′,10,11‐tetrahydro‐5H‐dibenzo[a,d]cyclohepten‐5‐yl‐2′(3′H)‐furans] as potential cytokine inhibitors

P. Ting, D. Solomon, 1995 .

Construction of trans-fused polycyclic ethers: methodology for the brevetoxins

P. Bartlett, P. Ting, 1986 .

Radical Cyclization of Oxime Ethers.

P. Bartlett, P. Ting, K. L. Mclaren, 1988 .

Synthesis of a series of sulfinic acid analogs of GABA and evaluation of their GABAB receptor affinities.

N. Carruthers, C. Rizzo, S. Wong, 1998, Bioorganic & medicinal chemistry letters.

The optimization of pyridazinone series of glucan synthase inhibitors.

R. J. Herr, Jianhua Cao, Jinhai Yang, 2012, Bioorganic & medicinal chemistry letters.

Synthesis of substituted 4(Z)-(methoxyimino)pentyl-1-piperidines as dual NK1/NK2 inhibitors.

J. Lee, N. Shih, J. Piwinski, 2001, Bioorganic & medicinal chemistry letters.

Synthesis of dibenzo[a,d]cycloheptanes as cytokine biosynthesis inhibitors

D. Zambas, P. Ting, Joe F. Lee, 1995 .

Discovery of oxazole-based PDE4 inhibitors with picomolar potency.

Jianhua Cao, H. Shue, R. Kuang, 2012, Bioorganic & medicinal chemistry letters.

Identification of a novel, orally bioavailable histamine H(3) receptor antagonist based on the 4-benzyl-(1H-imidazol-4-yl) template.

Xiaohong Zhu, Matthew Bryant, Xiaohong Zhu, 2002, Bioorganic & medicinal chemistry letters.

SAR studies of pyridazinone derivatives as novel glucan synthase inhibitors.

R. J. Herr, Jianhua Cao, Jinhai Yang, 2011, Bioorganic & medicinal chemistry letters.

Lead optimization of a sulfonylurea-based piperazine pyridazinone series of glucan synthase inhibitors.

R. J. Herr, S. Walker, R. Kuang, 2012, Bioorganic & medicinal chemistry letters.

Discovery of a Novel Class of Orally Active Antifungal β-1,3-d-Glucan Synthase Inhibitors

R. J. Herr, P. Mann, S. Walker, 2011, Antimicrobial Agents and Chemotherapy.

Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists.

Walter A. Korfmacher, M. Corboz, J. Hey, 2006, Bioorganic & medicinal chemistry letters.

Discovery of aminoquinazoline derivatives as human A(2A) adenosine receptor antagonists.

A. Stamford, R. Hodgson, Yongliang Zhang, 2016, Bioorganic & medicinal chemistry letters.

Lead optimization of a pyridine-carboxamide series as DGAT-1 inhibitors.

J. Lachowicz, J. Cook, S. Walker, 2013, Bioorganic & medicinal chemistry letters.

Discovery of novel quinoline carboxylic acid series as DGAT1 inhibitors.

J. Lachowicz, J. Cook, S. Walker, 2014, Bioorganic & medicinal chemistry letters.

Development of novel benzomorpholine class of diacylglycerol acyltransferase I inhibitors.

J. Lachowicz, J. Cook, S. Walker, 2014, ACS medicinal chemistry letters.

New agents to treat life-threatening fungal infections.

S. Walker, P. Ting, 2008, Current topics in medicinal chemistry.